Middle East Journal of Rehabilitation and Health Studies

Published by: Kowsar

Effect of Botulinum Toxin A (BTX-A) Injection into Denervated Muscles on Synkinesis and Symmetry in Patients with Facial Nerve Paralysis

Abbas Ali Pourmomeny 1 , * and Elham Pourali 1
Authors Information
1 Department of Physical Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Middle East Journal of Rehabilitation and Health: April 30, 2019, 6 (2); e81931
  • Published Online: February 18, 2019
  • Article Type: Review Article
  • Received: July 10, 2018
  • Revised: October 13, 2018
  • Accepted: December 26, 2018
  • DOI: 10.5812/mejrh.81931

To Cite: Pourmomeny A A, Pourali E. Effect of Botulinum Toxin A (BTX-A) Injection into Denervated Muscles on Synkinesis and Symmetry in Patients with Facial Nerve Paralysis, Middle East J Rehabil Health Stud. 2019 ; 6(2):e81931. doi: 10.5812/mejrh.81931.

Copyright © 2019, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
5. Conclusions
  • 1. Peitersen E. Bell's palsy: The spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4-30. [PubMed: 12482166].
  • 2. Roob G, Fazekas F, Hartung HP. Peripheral facial palsy: Etiology, diagnosis and treatment. Eur Neurol. 1999;41(1):3-9. doi: 10.1159/000007990. [PubMed: 9885321].
  • 3. Cronin GW, Steenerson RL. The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg. 2003;128(4):534-8. doi: 10.1016/S0194-59980300005-6. [PubMed: 12707657].
  • 4. de Maio M, Bento RF. Botulinum toxin in facial palsy: An effective treatment for contralateral hyperkinesis. Plast Reconstr Surg. 2007;120(4):917-27. discussion 928. doi: 10.1097/01.prs.0000244311.72941.9a. [PubMed: 17805119].
  • 5. Pepper JP, Kim JC. Selective chemodenervation with botulinum toxin in facial nerve disorders. Oper Tech Otolaryngol Head Neck Surg. 2012;23(4):297-305. doi: 10.1016/j.otot.2012.10.001.
  • 6. Crumley RL. Mechanisms of synkinesis. Laryngoscope. 1979;89(11):1847-54. doi: 10.1288/00005537-197911000-00020. [PubMed: 502707].
  • 7. Chuang DC, Chang TN, Lu JC. Postparalysis facial synkinesis: Clinical classification and surgical strategies. Plast Reconstr Surg Glob Open. 2015;3(3). e320. doi: 10.1097/GOX.0000000000000283. [PubMed: 25878931]. [PubMed Central: PMC4387142].
  • 8. Mehta RP, Hadlock TA. Botulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg. 2008;10(2):84-7. doi: 10.1001/archfaci.10.2.84. [PubMed: 18347234].
  • 9. Grundt B. Surgical treatment of seventh nerve paralysis. Br J Plast Surg. 1950;3(1):50-5. doi: 10.1016/S0007-1226(50)80009-7. [PubMed: 15411506].
  • 10. Pourmomeny AA, Zadmehre H, Mirshamsi M, Mahmodi Z. Prevention of synkinesis by biofeedback therapy: A randomized clinical trial. Otol Neurotol. 2014;35(4):739-42. doi: 10.1097/MAO.0000000000000217. [PubMed: 24317208].
  • 11. Pourmomeny AA, Asadi S. Management of synkinesis and asymmetry in facial nerve palsy: A review article. Iran J Otorhinolaryngol. 2014;26(77):251-6. [PubMed: 25320703]. [PubMed Central: PMC4196449].
  • 12. May M. Management of facial hyperkinesis. Overview of hyperkinesis. In: May M, Schaitkin BM, editors. The facial nerve. 2nd ed. New York: Thieme; 2000.
  • 13. Scott AB. Development of botulinum toxin therapy. Dermatol Clin. 2004;22(2):131-3. v. doi: 10.1016/S0733-8635(03)00019-6. [PubMed: 15222571].
  • 14. Kostrzewa RM, Segura-Aguilar J. Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea. Neurotox Res. 2007;12(4):275-90. doi: 10.1007/BF03033911. [PubMed: 18201955].
  • 15. Chen S. Clinical uses of botulinum neurotoxins: Current indications, limitations and future developments. Toxins (Basel). 2012;4(10):913-39. doi: 10.3390/toxins4100913. [PubMed: 23162705]. [PubMed Central: PMC3496996].
  • 16. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991;324(17):1186-94. doi: 10.1056/NEJM199104253241707. [PubMed: 2011163].
  • 17. Ward AB, Molenaers G, Colosimo C, Berardelli A. Clinical value of botulinum toxin in neurological indications. Eur J Neurol. 2006;13 Suppl 4:20-6. doi: 10.1111/j.1468-1331.2006.01650.x. [PubMed: 17112346].
  • 18. Boroojerdi B, Ferbert A, Schwarz M, Herath H, Noth J. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry. 1998;65(1):111-4. doi: 10.1136/jnnp.65.1.111. [PubMed: 9667571]. [PubMed Central: PMC2170154].
  • 19. Ito H, Ito H, Nakano S, Kusaka H. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Acta Neurol Scand. 2007;115(4):271-4. doi: 10.1111/j.1600-0404.2006.00746.x. [PubMed: 17376126].
  • 20. Borodic G, Bartley M, Slattery W, Glasscock M, Johnson E, Malazio C, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116(1):36-43. doi: 10.1097/01.PRS.0000169689.27829.C4. [PubMed: 15988245].
  • 21. Lee JM, Choi KH, Lim BW, Kim MW, Kim J. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg. 2015;68(1):71-8. doi: 10.1016/j.bjps.2014.08.067. [PubMed: 25444667].
  • 22. Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech. 2011;44(1):39-44. doi: 10.1016/j.jbiomech.2010.08.020. [PubMed: 20828699].
  • 23. Fortuna R, Vaz MA, Sawatsky A, Hart DA, Herzog W. A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles. J Biomech. 2015;48(10):1700-6. doi: 10.1016/j.jbiomech.2015.05.018.
  • 24. von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: An alternative treatment. Plast Reconstr Surg. 2001;107(2):327-32. doi: 10.1097/00006534-200102000-00004. [PubMed: 11214045].
  • 25. Lee CJ, Kim SG, Kim YJ, Han JY, Choi SH, Lee SI. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast Reconstr Surg. 2007;120(3):769-78. doi: 10.1097/01.prs.0000271068.71399.ae. [PubMed: 17700130].
  • 26. Choi KH, Rho SH, Lee JM, Jeon JH, Park SY, Kim J. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg. 2013;66(8):1058-63. doi: 10.1016/j.bjps.2013.04.012. [PubMed: 23683725].
  • 27. Yaraskavitch M, Leonard T, Herzog W. Botox produces functional weakness in non-injected muscles adjacent to the target muscle. J Biomech. 2008;41(4):897-902. doi: 10.1016/j.jbiomech.2007.11.016. [PubMed: 18184613].
  • 28. Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32(17):1414-8. doi: 10.3109/09638280903514697. [PubMed: 20156046].
  • 29. Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans. Mov Disord. 1997;12(1):89-94. doi: 10.1002/mds.870120115. [PubMed: 8990059].
  • 30. Dall'Angelo A, Mandrini S, Sala V, Pavese C, Carlisi E, Comelli M, et al. Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope. 2014;124(11):2513-7. doi: 10.1002/lary.24732. [PubMed: 24764160].
  • 31. Wei LA, Diels J, Lucarelli MJ. Treating buccinator with botulinum toxin in patients with facial synkinesis: A previously overlooked target. Ophthalmic Plast Reconstr Surg. 2016;32(2):138-41. doi: 10.1097/IOP.0000000000000449. [PubMed: 26325382].
  • 32. Mountain RE, Murray JAM, Quaba A. Management of facial synkinesis with Clostridium botulinum toxin injection. Clin Otolaryngol. 1992;17(3):223-4. doi: 10.1111/j.1365-2273.1992.tb01831.x.
  • 33. Roggenkamper P, Laskawi R, Damenz W, Schroder M, Nussgens Z. Orbicular synkinesis after facial paralysis: Treatment with botulinum toxin. Doc Ophthalmol. 1994;86(4):395-402. doi: 10.1007/BF01204598. [PubMed: 7835177].
  • 34. Chua CN, Quhill F, Jones E, Voon LW, Ahad M, Rowson N. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. 2004;23(4):213-8. doi: 10.1080/01676830490512233. [PubMed: 15590522].
  • 35. Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope. 2012;122(2):266-70. doi: 10.1002/lary.22404. [PubMed: 22252570].
  • 36. Navarrete Alvaro ML, Junyent J, Torrent L. [Botulinum toxin and facial palsy. Our experience]. Acta Otorrinolaringol Esp. 2010;61(4):277-81. Spanish. doi: 10.1016/j.otorri.2010.02.009. [PubMed: 20400055].
  • 37. Azuma T, Nakamura K, Takahashi M, Ohyama S, Toda N, Iwasaki H, et al. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg. 2012;146(1):40-5. doi: 10.1177/0194599811424125. [PubMed: 21965443].
  • 38. Monini S, De Carlo A, Biagini M, Buffoni A, Volpini L, Lazzarino AI, et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol. 2011;131(8):882-6. doi: 10.3109/00016489.2011.577447. [PubMed: 21534714].
  • 39. Pourmomeny AA, Asadi S, Cheatsaz A. Management of facial synkinesis with a combination of BTX-A and biofeedback: A randomized trial. Iran J Otorhinolaryngol. 2015;27(83):409-15. [PubMed: 26788484]. [PubMed Central: PMC4709755].
  • 40. Roggenkamper P, Laskawi R, Damenz W, Schroder M, Nussgens Z. [Involuntary lid closure caused by defective healing of facial paralysis and its treatment with botulinum toxin]. Klin Monbl Augenheilkd. 1991;198(4):268-70. German. doi: 10.1055/s-2008-1045963. [PubMed: 1861404].
  • 41. do Nascimento Remigio AF, Salles AG, de Faria JCM, Ferreira MC. Comparison of the efficacy of Onabotulinum toxin A and Abobotulinum toxin A at the 1: 3 conversion ratio for the treatment of asymmetry after long-term facial paralysis. Plast Reconstr Surg. 2015;135(1):239-49. doi: 10.1097/prs.0000000000000800.
  • 42. Kim J. Contralateral botulinum toxin injection to improve facial asymmetry after acute facial paralysis. Otol Neurotol. 2013;34(2):319-24. doi: 10.1097/MAO.0b013e31827c9f58. [PubMed: 23444480].
  • 43. Gooriah R, Ahmed F. Therapeutic uses of botulinum toxin. J Clin Toxicol. 2014;5(1). doi: 10.4172/2161-0495.1000225.
  • 44. May M, Croxson GR, Klein SR. Bell's palsy: Management of sequelae using EMG rehabilitation, botulinum toxin, and surgery. Am J Otol. 1989;10(3):220-9. [PubMed: 2750869].
  • 45. Beller M, Middaugh JP. Repeated type E botulism in an Alaskan Eskimo. N Engl J Med. 1990;322(12):855. doi: 10.1056/NEJM199003223221220. [PubMed: 2308624].
  • 46. Dressler D, Adib Saberi F. Botulinum toxin: Mechanisms of action. Eur Neurol. 2005;53(1):3-9. doi: 10.1159/000083259. [PubMed: 15650306].
  • 47. Ansved T, Odergren T, Borg K. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology. 1997;48(5):1440-2. doi: 10.1212/WNL.48.5.1440. [PubMed: 9153487].
  • 48. Girlanda P, Vita G, Nicolosi C, Milone S, Messina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry. 1992;55(9):844-5. doi: 10.1136/jnnp.55.9.844. [PubMed: 1328540]. [PubMed Central: PMC1015114].
  • 49. Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthalmic Plast Reconstr Surg. 2014;30(3):246-50. doi: 10.1097/IOP.0000000000000086. [PubMed: 24807539].
  • 50. Laskawi R, Damenz W, Roggenkamper P, Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol. 1994:S195-9. [PubMed: 10774349].
  • 51. Martinkaityte P, Griškevičiūtė R, Vieversyte M, Varžaitytė L, Savickas R. Rehabilitation strategies for facial nerve neuropathy. Health Sci. 2015;25(6):105-10.
  • 52. Sadiq SA, Khwaja S, Saeed SR. Botulinum toxin to improve lower facial symmetry in facial nerve palsy. Eye (Lond). 2012;26(11):1431-6. doi: 10.1038/eye.2012.189. [PubMed: 22975654]. [PubMed Central: PMC3496102].
  • 53. Cakmak MA, Sahin S, Cinar N, Karsidag S. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis. Acta Neurol Belg. 2014;114(4):331. doi: 10.1007/s13760-014-0287-x. [PubMed: 24647748].
  • 54. Kim J, Lee HR, Jeong JH, Lee WS. Features of facial asymmetry following incomplete recovery from facial paralysis. Yonsei Med J. 2010;51(6):943-8. doi: 10.3349/ymj.2010.51.6.943. [PubMed: 20879064]. [PubMed Central: PMC2995977].
  • 55. Beurskens CH, Oosterhof J, Nijhuis-van der Sanden MW. Frequency and location of synkineses in patients with peripheral facial nerve paresis. Otol Neurotol. 2010;31(4):671-5. doi: 10.1097/MAO.0b013e3181d8d84d. [PubMed: 20351606].
  • 56. Kayhan FT, Zurakowski D, Rauch SD. Toronto facial grading system: Interobserver reliability. Otolaryngol Head Neck Surg. 2000;122(2):212-5. doi: 10.1016/S0194-5998(00)70241-5. [PubMed: 10652392].
  • 57. Mehdizadeh OB, Diels J, White WM. Botulinum toxin in the treatment of facial paralysis. Facial Plast Surg Clin North Am. 2016;24(1):11-20. doi: 10.1016/j.fsc.2015.09.008. [PubMed: 26611697].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments